These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31795986)

  • 1. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
    Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
    BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.
    Wang MT; Liou JT; Lin CW; Tsai CL; Wang YH; Hsu YJ; Lai JH
    JAMA Intern Med; 2018 Feb; 178(2):229-238. PubMed ID: 29297057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?
    Adesanoye DT; Willey CJ
    Ann Pharmacother; 2017 Oct; 51(10):855-861. PubMed ID: 28573879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.
    Wang MT; Lai JH; Tsai CL; Liou JT
    J Food Drug Anal; 2019 Jul; 27(3):657-670. PubMed ID: 31324282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overuse of long-acting β
    Brunton SA; Hogarth DK
    Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
    Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials.
    Li C; Cheng W; Guo J; Guan W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():799-808. PubMed ID: 31114181
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities.
    Corrao S; Brunori G; Lupo U; Perticone F
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28794142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Wu J; Ye Y; Li C; Zhou W; Chang R
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):255-265. PubMed ID: 31306366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study.
    Suissa S; Dell'Aniello S; Ernst P
    Chest; 2017 Jan; 151(1):60-67. PubMed ID: 27554300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.
    Puhan MA; Bachmann LM; Kleijnen J; Ter Riet G; Kessels AG
    BMC Med; 2009 Jan; 7():2. PubMed ID: 19144173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment.
    Wood-Baker R; Cochrane B; Naughton MT
    Intern Med J; 2010 Feb; 40(2):94-101. PubMed ID: 19849745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease.
    Rogliani P; Calzetta L; Matera MG; di Daniele N; Girolami A; Cazzola M; Ora J
    Expert Opin Pharmacother; 2019 Apr; 20(6):737-750. PubMed ID: 30707637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.
    Manoharan A; Short PM; Anderson WJ; Lipworth BJ
    Lung; 2014 Oct; 192(5):649-52. PubMed ID: 24952426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.
    Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G
    COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study.
    Papi A; Forini G; Maniscalco M; Bargagli E; Crimi C; Santus P; Molino A; Bandiera V; Baraldi F; D'Anna SE; Carone M; Marvisi M; Pelaia C; Scioscia G; Patella V; Aliani M; Fabbri LM;
    Eur J Intern Med; 2024 Oct; 128():104-111. PubMed ID: 38981765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.